wire - news in brief

Research project iGUARD receives follow-up funding for the development of RNA-based drugs Despite successful vaccine development, there are still no effective drugs for most viral diseases.

At the Amyloidosis Centre Lower Saxony, MHH offers diagnostics and therapy to those affected by the disease Amyloidosis is a rare disease that can affect individual organs and body regions or the entire organism.

Cooperation between radiotherapy and cardiology: MHH experts achieve success with innovative treatment method Radiotherapy - most people think of it as the treatment of cancer.

International Lancet commission with MHH pneumologist Professor Dr Tobias Welte makes recommendations on prophylaxis, diagnosis and therapy Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease worldwide and the third leading cause of death.

MHH opens outpatient clinic to treat dysregulated sexuality in adolescents / Ministry of Social Affairs funds project with 300,000 euros Experts from the Department of Clinical Psychology and Sexual

MHH research team finds new AAV vectors for gene therapy in the heart muscle Gene therapies aim to cure severe, barely treatable monogentic diseases caused by a defect in a single gene.

Treatment of rare tumors: In addition to soft tissue tumors, the MHH is the only center in Lower Saxony to be certified for bone sarcomas.

EU supports multicentre project with a total of 6.75 million euros Hepatitis D is by far the most severe form of chronic viral hepatitis, often leading to liver failure, liver cancer and death.

Confidential help: medical staff secure traces of domestic and sexual violence Every third woman in Germany experiences physical and/or sexual violence at least once in her life.

MHH is a centre for high-risk pregnancies with pulmonary hypertension Little Amelie Maria lies in her mother's arms and looks curiously into the world with wide eyes.

Medical Informatics Initiative: MHH asks patients for support As of today, all inpatients at Hannover Medical School (MHH) can support medical research with their treatment data.

MHH Urology completes the treatment spectrum for benign prostate enlargement with two gentle procedures A frequent urge to urinate, going to the toilet at night, irregular urine stream - many men are familiar with these complaints.

MHH receives three million euros for research on artificial blood cells to counter shortages of blood reserves Blood transfusions are among the most common procedures in hospitals.

MHH programme PRACTIS for the training of clinician scientists is supported with 1.3 million euros for another two years In order to provide patients with the best possible care, the latest scientific findings must be incorporated into diagnostics and therapy.

DKG certifies excellent quality of care for women at increased risk of breast and/or ovarian cancer If there is a high incidence of breast and/or ovarian cancer in the family or if women develop the disease at a young age, this is usually due to hereditary causes.

Joint study by MHH and HZI: vaccine proves safe and effective against liver fibrosis and liver cancer Liver cancer is the third most common cause of cancer-related deaths worldwide. So far, the treatment options for two types of liver cancer, hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA), have been inadequate, while the number of new cases has been rising.

MHH Radiology puts computer tomograph with integrated laser navigation into operation Computer tomography (CT) is indispensable for modern diagnostics.

,,I had no recognizable symptoms" 14. Detecting lung cancer at an early stage: the HANSE Study, sponsored by the German Center for Lung Research (DZL) and the Lung Ambition Alliance, as the largest German early detection program, makes this its goal.

Research team with new development pipeline for RNA-based drugs successful in Europe-wide competition 08. Viruses are a major problem for human health worldwide - and not just since the outbreak of the SARS-CoV2 pandemic. Despite successful vaccine development, there are still no effective drugs for most viral diseases.

German Research Foundation supports MHH Department of Nuclear Medicine with around 900,000 euros for the expansion of molecular imaging In order to detect and research diseases, it is important to look inside the body.

Researchers include the 1000th patient in multicentre study Can digitoxin, an active ingredient from foxglove leaves, help patients with heart failure? Many things point to this, but it has not yet been scientifically investigated and proven.

International team takes important step towards better understanding the manifestations of the hereditary disease Li-Fraumeni syndrome (LFS) is associated with a dramatically increased lifelong risk of a broad spectrum of cancers and is caused by pathogenic variants in the TP53 gene.

Nationwide study with data from 50 years determines cancer risk of affected children Fanconi anaemia (FA) and ataxia teleangiectatica (AT) belong to the so-called cancer predisposition syndromes.